In Part 3 of our podcast series about anticoagulation, James talks to Dr Ed Abadir about the use of new oral anticoagulants, DOACs or NOACs, as alternatives to warfarin and heparin on the wards.
In Part 1 we discussed warfarin and in Part 2 we talked about heparin. To catch up on those podcasts, please visit Anticoagulation 1: Warfarin and Anticoagulation 2: Heparin.
Script Writer: Laura Glenn
Editor: James Edwards
Interviewee: Ed Abadir
Edward Abadir is currently a Haematology registrar at Royal Prince Alfred Hospital and Concord Hospital. He studied medicine at the University of Sydney prior to internship and completed his residency at Royal Prince Alfred Hospital. Ed completed his Basic Physicians Training at Royal Prince Alfred Hospital in 2013.
With Dr Ed Abadir, Haematology registrar at Royal Prince Alfred Hospital & Concord Hospital, New South Wales, Australia.
This podcast is about new oral anticoagulants, which are now commonly being used as alternatives to warfarin and heparin for both prophylactic and therapeutic anticoagulation.
If you enjoyed listening to this week’s podcast feel free to let us know what you think by posting your comments or suggestions in the comments box below.
If you want to listen to this episode while not connected to WiFi or the internet, you can download it. To find out more go to Apple support (https://support.apple.com/en-us/HT201859)